Study to Assess the Effect of Food on the Concentration of GW273225 in the Body of Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 6, 2007

Primary Completion Date

October 11, 2007

Study Completion Date

October 11, 2007

Conditions

Bipolar Disorder

Interventions

DRUG

GW273225

GW273225 will be available as white tablets containing 25 mg GW273225.The study drug will be taken with 240 milliliters of water at room temperature.

Trial Locations (1)

GSK Investigational Site, Cambridge